Pulmonary abcess, a revision

Ana Moura Gonçalves 1

Luiz Menezes Falcão 2

Luciano Ravara 3

Resumo

Os abcessos pulmonares são cavidades que surgem no parênquima pulmonar, apresentando maior ou menor quantidade de tecido necrosado no seu interior. Surgem em indivíduos predispostos, como sejam os doentes com doença pulmonar crónica ou obstrução secundária a neoplasia e os doentes com maior risco de aspiração, estando incluidos os doentes com alteração do estado neurológico, os utilizadores de drogas endovenosas, os doentes com alcoolismo, patologia da faringe e esofágica, doença neuromuscular, entre outras. É feita a revisão dos principais agentes causais, da metodologia diagnóstica, da abordagem terapêutica na actualidade e do prognóstico destas situações.

Palavras-chave: Abcesso pulmonar, pneumonia de aspiração, resistência antimicrobiana, anaeróbios.

Abstract

Lung abscesses are cavitating lesions containing necrotic debris caused by microbial infection. Patients with chronic lung disease, bronchial obstruction secondary to cancer, a history of aspiration or risk of aspiration caused by alcoholism, altered mental status, structural or physiologic alterations of the pharynx and esophagus, neuromuscular disorders, anesthesia, are among others at higher risk of developing lung abcess.

The main bacteriological characteristics, the diagnosis, therapy and prognosis are considered. The problem of antimicrobial resistance is also referred.

Key-words: Lung abscesses, aspiration pneumonia, antimicrobial resistance, anaerobes

Full text only available in PDF format.

Bibliografia

1. Tan QT, Seilheimer DK., Kaplan SL. Pediatric lung abscess: clinical management and outcome. Pediatric Infect Dis J 1995; 14:51-5.         [ Links ]

2. Bartlett JG. Anaerobic bacterial pleuropulmonary infections. Semin Respir Med 1992; 13:159-64.

3. Smith DT. Experimental aspiratory abscess. Arch Surg 1927; 14:231-9.

4. Smith DT. Fuso-spirochetal disease of the lungs. Tubercle 1928; 9:420.

6. Bartlett JG: HIV infection and surgeons. Curr Probl Surg 1992; 197-280.

7. Pohlson EC, McNamara JJ, Char C, et al: Lung abscess: a changing pattern of the disease. Am J Surg 1985 Jul; 150:97-101.

8. Hirshberg B, Sklair-Levi M, Nir-Paz R:Factors predicting mortality of patients with lung abscess. Chest 1999 Mar; 115:746-50.

9. Bartlett, JG. Lung abscess and the necrotizing pneumonia. In: Gorbach SL, Bartlett JG, Blacklow NR (Eds.). Infectious Diseases. WB Saunders, Philadelphia 1992.

10. Davis B, Systrom DM. Lung abscess: pathogenesis, diagnosis and treatment. Curr Clin Topics Infect Dis 1998; 18:252-73.

11. Wang J-L, Chen K-Y, Fang C-T et al. Changing Bacteriology of Adult Community-Acquired Lung Abscess in Taiwan: Klebsiella pneumoniae versus Anaerobes. CID 2005; 40:915-22.

12. Yoneyama T, Yoshida M, Matsui T, Sasaki H. Oral care and pneumonia. Lancet 1999; 354:515.

13. Chung G, Goetz MB. Anaerobic infections of the lung. Curr Infect Dis Rep 2000; 2:238-44.

14. Marik PE. Aspiration pneumonitis and aspiration pneumonia. N Engl J Med 2001; 344(9):665-71.

16. Moine P, Vercken JP, Chevret S, Chastang C, Gajdos P. Severe Community-acquired pneumonia: etiology, epidemiology, and prognosis factors. Chest 1994; 105:1487-95.

17. Olsson GL, Hallen B, Hambraeus-Jonzon K. Aspiration during anaesthesia: a computer-aided study of 185.358 anaesthesics. Acta Anaesthesiol Scand 1986; 30:84-92.

18. Holas MA, DePippo KL, Reding MJ. Aspiration and relative risk of medical complications following stroke. Arch Neurol 1994; 51:1051-3.

19. Mann G, Hankey GJ, Cameron D. Swallowing function after stroke: prognosis and prognostic factors at 6 months. Stroke 1999; 30:744 -8.

20. Roy TM, Ossorio MA, Cipolla LM, Fields CL, Snider HL, Anderson WH. Pulmonary complications after tricyclic antidepressant overdose. Chest 1989; 96:852-6.

21. Aldrich T, Morrison J, Cesário T. Aspiration after overdosage of sedative or hypnotic drugs. South Med J 1980; 73:456-8.

22. Warner MA, Warner ME, Weber JG. Clinical significance of pulmonary aspiration during the perioperative period. Anesthesiology 1993; 78:56-62.

23. Bartlett JG, Gorbach SL, Tally FP, Finegold SM. Bacteriology and treatment of primary lung abscess. AM Rev Respir Dis 1974; 109:510.

24. Fisher AM, Trever RW, Curtin JA et al. Staphylococcal pneumonia; a review of 21 cases in adults. N Engl J Med 1958; 258:919-28.

26. Bartlett JG. Anaerobic bacterial infections of the lung. Chest 1987; 91:901-9.

27. Bartlett JG. Anaerobic bacterial infections of the lung and pleural space. Clin Infect Dis 1993;16: S248-55.

28. Clinical conferences at the Johns Hopkins Hospital: lung abscess. Johns Hopkins Med J 1982; 150:141-7.

29. Pfitzner J, Peacock MJ, Tsirgiotis E, Walkley H. Lobectomy for cavitating lung abscess with haemoptysis: Strategy for protecting the contralateral lung and also the non-involved lobe of the ipsilateral lung. Br J Anaesth 2000; 85, n.º 5:791-4.

30. Stark DD, Federle MP, Goodman PC et al. Differentiating lung abscess and empyema: radiography and computed tomography. Am J Roentgenol 1983; 141:163-7.

31. Irwin RS, Garrity FL, Erickson AD, Corrao WM, Kaemmerlen JT. Sampling lower respiratory tract secretions in primary lung abscess: a comparison of the accuracy of four methods. Chest 1981; 79:559-65.

32. Bartlett JG. The technique of transtracheal aspiration. J Crit Iln 1986; 1:43-9.

33. Bartlett JG. Diagnostic accuracy of transtracheal aspiration bacteriology. Am Rev Respir Dis 1977; 115:777-82.

34. Small PM, Fujiwara PI. Management of Tuberculosis in the United States. N Engl J Med 2001; 345, n.º 3:189-200.

36. Bandt PD, Blank N, Castellino RA. Needle diagnosis of pneumonitis. Value in high-risk patients. JAMA 1972; 220:1578-80.

37. Wimberley NW, Bass JB, Boyd BW, et al. Use of a bronchoscopic protected catheter brush for the diagnosis of pulmonary infections. Chest 1982; 81:556-62.

38. Gudiol F, Manresa F, Pallares R, et al. Clindamicyn vs penicillin for anaerobic lung infections: high rate of penicillin failures associated with penicillin-resistant Bacteroides melaninogenicus. Arch Intern Med 1990; 150:2525-9.

39. Bartlett JG, Gorbach SL. Penicillin or clindamycin for primary lung abscess? Ann Intern Med 1983; 98:546-8.

40. Teng LJ, Hsueh PR, Tsai JC, Liaw SJ, Ho SW, Luh KT. High incidence of cefoxitin and clindamycin resistance among anaerobes in Taiwan. Antimicrob Agents Chemother 2002; 46:2908-13.

41. Appelbaum PC, Spangler SK, Jacobs MR. â-Lactamase production and susceptibilities to amoxicillin, amoxicillinclavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem and metronidazole of 320 non- Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 US centers. Antimicrob Agents Chemother 1990; 34:1546-50.

42. Smith DT. Medical treatment of acute and chronic pulmonary abscesses. J Thorac Surg 1942; 17:72-5.

43. Allen CI, Blackman JF. Treatment of lung abscess with report of 100 consecutive cases. J Thorac Surg 1936; 6:156-62.

44. Harber P, Terry PB. Fatal Lung Abscesses: Review of 11 years experience. South Med J 1981; 74:281-3.

46. Pohlson EC, Mc Namara JJ, Char C, et al. Lung abscess: a changing pattern of the disease. Am J Surg 1985; 150:97-101.

47. Bartlett JG. Lung abscess. In Baum GL, Wolinsky E (Eds.). Textbook of Pulmonary Diseases. 5 th ed. Boston, MA: Little Brown and Company, 1994; 607-20.

1 Interna do Internato Complementar de Medicina Interna, no Hospital de Santa Maria, Lisboa.

2 Assistente Hospitalar Graduado do Hospital de Santa Maria, Cardiologista, Professor Auxiliar da Faculdade de Medicina de Lisboa.

3 Professor Catedrático da Faculdade de Medicina de Lisboa, Director do Serviço de Medicina 1 do Hospital de Santa Maria, Lisboa.

Serviço de Medicina 1– sector C, Hospital de Santa Maria, Lisboa

Director: Professor Dr. Luciano Ravara

e-mail: anapmgoncalves@gmail.com

Recebido para publicação/received for publication: 06.05.17

Aceite para publicação/accepted for publication: 07.09.12